Combining Buspar (Buspirone) and Wellbutrin (Bupropion): Precautions and Interactions

Safety Profile and Potential Interactions

The combination of buspirone and bupropion is generally considered safe with no major drug-drug interactions, but requires monitoring for neuropsychiatric effects, seizure risk, and potential additive side effects, as recommended by the American College of Obstetricians and Gynecologists and the National Comprehensive Cancer Network 1, 2
Buspirone and bupropion do not have any direct pharmacokinetic interactions that would significantly affect blood levels of either medication, according to the American College of Obstetricians and Gynecologists 1
No specific contraindications exist for using these medications together in major clinical guidelines, as stated by the National Comprehensive Cancer Network and the American Diabetes Association 3, 4

Bupropion lowers the seizure threshold with a documented 0.1% seizure risk in clinical trials, as reported by the National Comprehensive Cancer Network 5
Patients with a history of seizures, brain metastases, or other neurological conditions that lower the seizure threshold should avoid bupropion, as recommended by the National Comprehensive Cancer Network 3, 2

Both medications can potentially cause neuropsychiatric effects, though these are generally mild, according to the American College of Obstetricians and Gynecologists and the National Comprehensive Cancer Network 1, 2
Monitor for changes in mood, including worsening depression or anxiety, as recommended by the National Comprehensive Cancer Network 2
Suicidal ideation, especially in patients younger than 24 years, should be monitored, as stated by the American Diabetes Association 4

Bupropion may cause mild increases in blood pressure and heart rate, as reported by the National Comprehensive Cancer Network 2
Regular monitoring of vital signs is recommended, especially in patients with pre-existing cardiovascular conditions, as recommended by the American Gastroenterological Association 6
The combination should be avoided in patients with uncontrolled hypertension, as stated by the American Gastroenterological Association 6

Headache, dizziness, and insomnia are common with both medications, as reported by the National Comprehensive Cancer Network 2
Gastrointestinal effects including nausea, dry mouth, and constipation should be monitored, as recommended by the National Comprehensive Cancer Network 2

Avoid combining with MAO inhibitors - bupropion is contraindicated for use with these medications due to risk of hypertensive reactions, as recommended by the National Comprehensive Cancer Network 3
If opioid medications are needed, be aware that bupropion in combination with naltrexone could affect opioid efficacy, as reported by the American Gastroenterological Association 6

Start with lower doses of both medications and titrate slowly to minimize side effects, as recommended by the American College of Obstetricians and Gynecologists 1
Standard dosing for bupropion SR is 150 mg once daily initially, increasing to twice daily if tolerated, as stated by the National Comprehensive Cancer Network 3

Bupropion may be particularly beneficial for patients with depression, as reported by the National Comprehensive Cancer Network 2, 5
The combination may be helpful for patients who need treatment for both anxiety and depression, as recommended by the American College of Obstetricians and Gynecologists 1
Bupropion can also be beneficial for smoking cessation, which may be an additional benefit for some patients, as reported by the National Comprehensive Cancer Network 7, 2

Regular follow-up visits to assess efficacy and side effects are recommended, as stated by the National Comprehensive Cancer Network 2
Monitor vital signs, particularly blood pressure and heart rate, as recommended by the American Gastroenterological Association 6
Assess for emergence of neuropsychiatric symptoms, especially during dose adjustments, as recommended by the National Comprehensive Cancer Network 2
Discontinue or adjust dosing if significant side effects occur, as stated by the National Comprehensive Cancer Network 3